Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
Myeloid kinome inhibitor
DRUG CLASS:
Myeloid kinome inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
CG-806 (6)
HM43239 (2)
CG-806 (6)
HM43239 (2)
›
Associations
(8)
News
Trials
VERI cancer hierarchy
Reset Filters
FLT3 mutation
Acute Myelogenous Leukemia
FLT3 mutation
Acute Myelogenous Leukemia
HM43239
Sensitive: B - Late Trials
HM43239
Sensitive
:
B
HM43239
Sensitive: B - Late Trials
HM43239
Sensitive
:
B
FLT3 wild-type
Acute Myelogenous Leukemia
FLT3 wild-type
Acute Myelogenous Leukemia
HM43239
Sensitive: C3 – Early Trials
HM43239
Sensitive
:
C3
HM43239
Sensitive: C3 – Early Trials
HM43239
Sensitive
:
C3
FLT3‐ITD
Acute Myelogenous Leukemia
FLT3‐ITD
Acute Myelogenous Leukemia
CG-806
Sensitive: C3 – Early Trials
CG-806
Sensitive
:
C3
CG-806
Sensitive: C3 – Early Trials
CG-806
Sensitive
:
C3
FLT3‐ITD mutation + DNMT3A mutation + NPM1 mutation
Acute Myelogenous Leukemia
FLT3‐ITD mutation + DNMT3A mutation + NPM1 mutation
Acute Myelogenous Leukemia
CG-806
Sensitive: C4 – Case Studies
CG-806
Sensitive
:
C4
CG-806
Sensitive: C4 – Case Studies
CG-806
Sensitive
:
C4
TNFSF13B negative
Non-Hodgkin’s Lymphoma
TNFSF13B negative
Non-Hodgkin’s Lymphoma
CG-806
Sensitive: D – Preclinical
CG-806
Sensitive
:
D
CG-806
Sensitive: D – Preclinical
CG-806
Sensitive
:
D
CD40L negative
Non-Hodgkin’s Lymphoma
CD40L negative
Non-Hodgkin’s Lymphoma
CG-806
Sensitive: D – Preclinical
CG-806
Sensitive
:
D
CG-806
Sensitive: D – Preclinical
CG-806
Sensitive
:
D
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
CG-806
Sensitive: D – Preclinical
CG-806
Sensitive
:
D
CG-806
Sensitive: D – Preclinical
CG-806
Sensitive
:
D
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
MYC overexpression + BCL2 overexpression
Diffuse Large B Cell Lymphoma
venetoclax + CG-806
Sensitive: D – Preclinical
venetoclax + CG-806
Sensitive
:
D
venetoclax + CG-806
Sensitive: D – Preclinical
venetoclax + CG-806
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login